Centre of Evidence Based Dermatology
  • Print

Cellulitis Priority Setting Partnership (PSP)


Cellulitis is an acute, painful and potentially serious infection of the skin. It is very common and is often managed in primary care but also accounts for around 2-3% of hospital admissions. Cellulitis is a relatively under-researched topic area. However, the number of people affected by cellulitis and the associated complications of cellulitis alone demonstrate the need for further research into the diagnosis, treatment and prevention of this condition.

To address this, the James Lind Alliance Cellulitis Priority Setting Partnership (PSP) has been set up to identify and prioritise research questions that are important to people with cellulitis (their carers/parents of affected children) and healthcare professionals involved in their care.

The project is being funded by the UK Dermatology Clinical Trials Network (UKDCTN) and will be co‐ordinated by the Centre of Evidence Based Dermatology




Key Facts

1. What does the PSP involve? 

The partnership held its first meeting in January 2016. A survey is now underway which is aimed at identifying questions that patients, carers or clinicians may have on the diagnosis, treatment and prevention of cellulitis. A summary of the whole process is shown below. It will take about one year to complete.



2. Who is involved?

The partner organisations involved in promoting the Cellulitis PSP are as follows:

•    UK Dermatology Clinical Trials Network (UKDCTN)

•    British Association of Dermatologists (BAD)

•    Primary Care Dermatology Society

•    British Society for Medical Dermatology

•    Lymphoedema Support Network (LSN)

•    British Lymphology Society

•    Manual Lymphatic Drainage (MLD) UK

•    Children’s Lymphoedema Special Interest Group

•    Leg Ulcer Forum

•    Royal College of General Practitioners

•    General Practice Research on Infections Network

•    Society for Academic Primary Care

•    Royal College of Emergency Medicine

•    British Infections Association

•    Leg Clubs

3. How can I take part?

A survey is currently underway which asks what questions about the diagnosis, treatment and prevention of cellulitis that you would like to see answered by research. Examples of questions from other health conditions are: “Are exercise programmes after a stroke beneficial at improving quality of life and avoiding subsequent strokes?” or “Which insulins are safest to use for diabetes and have the fewest adverse effects?”

We ask that you tell us any questions you have about the diagnosis, treatment or prevention of cellulitis. These questions do not have to be in any particular order of importance.

4. What happens with the results of the survey?

Once the survey is complete all the responses will be collated. We will use these responses to identify where there is a true question (that is to say where there is no existing research that already provides a reliable answer). The most commonly asked questions from this survey, about the diagnosis, treatment and prevention of cellulitis, will then be collated and voted on in a second survey.

5. What is the second survey for? 

In the second survey we will provide you with the most frequently asked questions about the diagnosis, treatment and prevention of cellulitis from the initial survey. We will ask you to read the list of questions and vote for which you think are the most important to you.

6. What will happen to the results of the study? 

The uncertainties that are identified during this project will be published on the JLA website and used to inform future research funding. The results will be made available on this website as well as through partner organisations’ websites and social media. We will also publish the results in the scientific press. You will not be identified in any publication. We will also make funding bodies aware of the Top 10 questions to help raise the profile of cellulitis research.


Further information

For further information about the process of Priority Setting Partnerships please see the James Lind Alliance website.




Contact us


Partner Organisations




































Centre of Evidence Based Dermatology

The University of Nottingham
King's Meadow Campus
Lenton Lane
Nottingham, NG7 2NR

telephone: +44 (0) 115 823 1048